Efficacy and safety of intranasal haloperidol in an acute Psychiatry Unit: a pilot study on schizophrenic patients with mild-modedate agitation

To study the efficacy and safety of intranasal administration of 5 mg haloperidol on mild-moderate agitated patients with schizophrenia or schizoaffective disorder in an acute psychiatry unit setting

Detalles Bibliográficos
Autores principales: Rosó, Duñó Ambròs, Joan Carles, Oliva Morera, María Luisa, Iglesias-Lepine, Diego, Palao Vidal, José Antonio Monreal Ortiz, Monreal Ortiz, Javier, Labad Arias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Actas Espanolas Psiquiatria 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335081/
https://www.ncbi.nlm.nih.gov/pubmed/34533203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335081/
https://www.ncbi.nlm.nih.gov/pubmed/34533203

Ejemplares similares